Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.91% | 74.43 | 0.0% | $2402.36m | |
| NVAX | Novavax, Inc. | 1.57% | 170.13 | 99.2% | $1227.79m | |
| SRNE | Sorrento Therapeutics, Inc. | 4.63% | 14.24 | 1.8% | $561.81m | |
| GILD | Gilead Sciences, Inc. | 0.19% | 68.94 | 1.0% | $550.36m | |
| AMGN | Amgen, Inc. | -0.38% | 240.64 | 1.3% | $483.55m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.48% | 624.19 | 2.5% | $438.75m | |
| BNTX | BioNTech SE | 0.60% | 77.54 | 0.0% | $396.78m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.71% | 275.27 | 1.9% | $377.82m | |
| BIIB | Biogen, Inc. | 8.78% | 302.05 | 1.6% | $340.47m | |
| VXRT | Vaxart, Inc. | 2.58% | 9.33 | 0.0% | $292.69m | |
| ILMN | Illumina, Inc. | -13.52% | 345.34 | 3.5% | $277.47m | |
| EBS | Emergent BioSolutions, Inc. | 2.35% | 129.94 | 6.4% | $180.09m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.69% | 103.18 | 1.9% | $168.98m | |
| SGEN | Seattle Genetics, Inc. | -0.26% | 161.38 | 6.0% | $165.38m | |
| IBIO | iBio, Inc. | -3.45% | 3.92 | 0.2% | $163.75m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.